Atnaujinkite slapukų nuostatas

El. knyga: 2023 Nelson's Pediatric Antimicrobial Therapy

Edited by , Edited by , Edited by , Edited by , Edited by , Edited by , Edited by , Edited by , Edited by
  • Formatas: 384 pages
  • Išleidimo metai: 08-Mar-2023
  • Leidėjas: American Academy of Pediatrics
  • Kalba: eng
  • ISBN-13: 9781610026512
  • Formatas: 384 pages
  • Išleidimo metai: 08-Mar-2023
  • Leidėjas: American Academy of Pediatrics
  • Kalba: eng
  • ISBN-13: 9781610026512

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Completely updated and revised, the 29th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.
 
For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.
Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
 
CHAPTERS INCLUDE
  • Antimicrobial Therapy According to Clinical Syndromes
  • Antimicrobial Therapy for Neonates
  • Choosing Among
    • Antibiotics
    • Antifungal Agents
    • Antiviral Agents
    • Antiparasitic Agents
  • Oral Step-down Therapy for Serious Infections
  • Prevention of Symptomatic Infection
  • Approach to Antibiotic Allergies
  • Antibiotic Stewardship
  • Antibiotic Therapy for Children With Obesity


Completely updated and revised, the 29th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.

Recenzijos

A 2023 Doodys Core Title®

"This book is an incredibly well-organized, up-to-date, well-presented quick reference for clinicians who treat infections in pediatric patients. I have been using the book since its earliest edition, and it keeps on improving. I highly recommend this book as an easily accessible, current, and concise reference for providers at every level." - Joseph Russell Hageman, MD (Comer Children's Hospital)

Introduction ix
Notable Changes to 2023 Nelson's Pediatric Antimicrobial Therapy, 29th Edition xiii
1 Antimicrobial Therapy According to Clinical Syndromes
1(76)
A Skin and Soft Tissue Infections
4(6)
B Skeletal Infections
10(4)
C Eye Infections
14(4)
D Ear and Sinus Infections
18(4)
E Oropharyngeal Infections
22(3)
F Lower Respiratory Tract Infections
25(14)
G Cardiovascular Infections
39(9)
H Gastrointestinal Infections
48(7)
I Genital and Sexually Transmitted Infections
55(5)
J Central Nervous System Infections
60(5)
K Urinary Tract Infections
65(2)
L Miscellaneous Systemic Infections
67(10)
2 Antimicrobial Therapy for Neonates
77(32)
A Recommended Therapy for Select Neonatal Conditions
80(22)
B Antimicrobial Dosages for Neonates
102(4)
C Aminoglycosides
106(1)
D Vancomycin
107(1)
E Use of Antimicrobials During Pregnancy or Breastfeeding
107(2)
3 Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
109(34)
A Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
110(2)
B Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
112(2)
C Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
114(2)
D Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
116(27)
4 Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
143(8)
5 Preferred Therapy for Specific Fungal Pathogens
151(22)
A Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
152(2)
B Systemic Infections
154(16)
C Localized Mucocutaneous Infections
170(3)
6 Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
173(10)
7 Preferred Therapy for Specific Viral Pathogens
183(20)
A Overview of Non-HIV, Non-hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
184(1)
B Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
185(1)
C Preferred Therapy for Specific Viral Pathogens
186(17)
8 Choosing Among Antiviral Agents
203(4)
9 Preferred Therapy for Specific Parasitic Pathogens
207(26)
A Select Common Pathogenic Parasites and Suggested Agents for Treatment
208(2)
B Preferred Therapy for Specific Parasitic Pathogens
210(23)
10 Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and Neglected Tropical Diseases
233(2)
11 How Antibiotic Dosages Are Determined by Use of Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
235(4)
12 Approach to Antibiotic Therapy for Drug-Resistant Gram-negative Bacilli and Methicillin-Resistant Staphylococcus aureus
239(10)
13 Antibiotic Therapy for Children With Obesity
249(4)
14 Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
253(2)
15 Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
255(18)
A Postexposure Antimicrobial Prophylaxis to Prevent Infection
257(7)
B Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
264(2)
C Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
266(1)
D Surgical/Procedure Prophylaxis
267(6)
16 Approach to Antibiotic Allergies
273(10)
17 Antibiotic Stewardship
283(6)
18 Systemic and Topical Antimicrobial Dosing and Dose Forms
289(36)
A Systemic Antimicrobials With Dosage Forms and Usual Dosages
291(26)
B Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
317(8)
Appendix: Nomogram for Determining Body Surface Area 325(2)
References 327(26)
Index 353
John S. Bradley, MD, FAAP, has been the Medical Director of the Division of Infectious Diseases at Rady Children's Hospital-San Diego since 1988, and is currently Distinguished Professor of Pediatrics, Division of Infectious Diseases, Department of Pediatrics, University of California, San Diego School of Medicine. He has served on the American Academy of Pediatrics Committee on Infectious Diseases (Red Book Committee) 2004-2010, and the Council of the Pediatric Infectious Diseases Society (PIDS) Council, 2007-2011 where he promoted the development of a PIDS Antimicrobial Stewardship program.

John D. Nelson, MD Emeritus is Professor Emeritus of Pediatrics at the University of Texas Southwestern Medical Center and Children's Medical Center, the same institution since he started his career back in 1957. At UT Southwestern he established the first formal Pediatric Infectious Disease fellowship program with Dr. Kenneth Haltalin and later Dr. George McCracken. He also went on to establish the National Pediatric Infectious Disease Seminar with Dr. McCracken and in 1982 they founded the Pediatric Infectious Disease Journal for which they continue as Chief Editors. In 1975 Dr. Nelson produced the first edition of the Pocket Book of Pediatric Antimicrobial Therapy which has gone through 20 biennial editions and is now edited by Dr. John Bradley.

Elizabeth D. Barnett, MD, FAAP is the Professor of Pediatrics at Boston University School of Medicine and the Director, International Clinic in the Division of Pediatric Infectious Diseases at Boston Medical Center.

Joseph B. Cantey, MD, FAAP  is an Assistant Professor of Pediatrics in the Divisions of Pediatric Infectious Diseases and Neonatology/Perinatal Medicine at the University of Texas Health Science Center in San Antonio. He attended medical school at the Medical University of South Carolina before completing his pediatric residency at Johns Hopkins. He then completed dual fellowships in pediatric infectious diseases and neonatal/perinatal medicine at the University of Texas Southwestern in Dallas, Texas. His research interests include antimicrobial stewardship and responsible prescribing in the nursery setting; infection control and prevention in the nursery setting; and the pathogenesis, diagnosis, treatment, and longitudinal follow-up of congenital and perinatal infections, particularly herpes simplex virus, cytomegalovirus, and syphilis.

David W. Kimberlin, MD, FAAP, is the Editor of the 2021 AAP Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2015 and 2018 editions, and was an Associate Editor of the 2012 and 2009 editions, and served on the AAP Committee on Infectious Diseases from 2005- 2011. Dr Kimberlin is Professor of Pediatrics and Co-director, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham. His clinical and research interests include pediatric infectious diseases, antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome.

Paul E. Palumbo, MD is Professor of Pediatrics and Medicine at Geisel School of Medicine at Dartmouth College and Director, International Pediatric HIV Program at the Dartmouth-Hitchcock Medical Center. He specializes in pediatric HIV and TB disease.

Jason Sauberan, PharmD is Assistant Clinical Professor at the University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences and a pediatric consultant pharmacist at the Helen Bernardy Center for Medically Fragile Children, Rady Childrens Hospital San Diego. His research interests include anti-infection therapy, drugs in breast milk, parenteral nutrition, and medication safety. He serves on the Scientific Advisory Board of Mother to Baby California, and is an assistant clinical professor, UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences.

J. Howard Smart, MD, FAAP has been practicing General Pediatrics in San Diego since 1996 after completing his residency, which included working with Dr. John S. Bradley at Childrens Hospital (now Radys) in San Diego. He is Chairman of the Department of Pediatrics at Sharp Rees-Stealy Medical Group and Assistant Clinical Professor of Pediatrics in the UCSD residents clinic. His involvement with Nelsons started with a conversation with Dr. Bradley while flying to an AAP conference, discussing his hobby of mobile app development. Dr. Smart has been an app developer since 2011, and brings together the two knowledge domains of computer science and pediatrics in creating the mobile version of Nelsons.

William J. Steinbach, MD, FAAP is the Robert H. Fiser, Jr, MD, Endowed Chair in Pediatrics; Chair, Department of Pediatrics; and Associate Dean for Child Health at the University of Arkansas for Medical Sciences and the Pediatrician-in-Chief, Arkansas Childrens in Little Rock, AR. His expertise is in transplant infectious diseases, specifically in invasive fungal disease in children. He leads an integrated molecular, translational, and clinical research effort toward improving our understanding of invasive fungal disease epidemiology, diagnosis, and treatment.